Literature DB >> 3881037

Pathology of hepatic transplantation: A review of 62 adult allograft recipients immunosuppressed with a cyclosporine/steroid regimen.

A J Demetris, S Lasky, D H Van Thiel, T E Starzl, A Dekker.   

Abstract

The pathologic specimens (n = 118) and hospital course pertinent to each of 62 adult liver allograft recipients were reviewed. Biopsies and retransplanted organs were obtained at the discretion of the surgical team on the basis of the postoperative clinical course (less than 1 day to greater than 12 years after transplantation), and final interpretation of the pathologic material was based on a correlation of all available data. Most of the specimens (n = 85) were obtained within the first 2 months, and diagnoses in this time period included rejection, biliary obstruction/cholangitis, vascular injury, herpesvirus and cytomegalovirus hepatitis, graft necrosis, and functional cholestasis. Thereafter, rejection and recurrent or primary viral hepatitis were the major causes of graft dysfunction. Histologically, hepatic rejection is manifested by a cellular mediated injury of hepatocytes and bile ductules and a spectrum of vascular lesions in medium-sized hilar arteries. Morphologic changes of biliary duct obstruction and viral liver disease were at times difficult to differentiate from rejection. Two pretransplant disorders, type B viral hepatitis and the Budd-Chiari syndrome, recurred in grafted organs. Although interpretation of pathologic material may be difficult at times, it frequently is helpful in planning an approach to management of liver allograft recipients.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3881037      PMCID: PMC1887859     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  31 in total

1.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

2.  The graft-versus-host reaction.

Authors:  T A Seemayer; J G Gartner; W S Lapp
Journal:  Hum Pathol       Date:  1983-01       Impact factor: 3.466

Review 3.  Evolution of liver transplantation.

Authors:  T E Starzl; S Iwatsuki; D H Van Thiel; J C Gartner; B J Zitelli; J J Malatack; R R Schade; B W Shaw; T R Hakala; J T Rosenthal; K A Porter
Journal:  Hepatology       Date:  1982 Sep-Oct       Impact factor: 17.425

4.  Ductular damage in liver transplant rejection: its similarity to that of primary biliary cirrhosis and graft-versus-host disease.

Authors:  R H Fennell
Journal:  Pathol Annu       Date:  1981

5.  Expression of Ia antigen on epidermal keratinocytes in graft-versus-host disease.

Authors:  I A Lampert; A J Suitters; P M Chisholm
Journal:  Nature       Date:  1981 Sep 10-16       Impact factor: 49.962

6.  Fatalities following exposure to 2-nitropropane.

Authors:  C H Hine; A Pasi; B G Stephens
Journal:  J Occup Med       Date:  1978-05

7.  Pathology of liver transplantation.

Authors:  H Roddy; C W Putnam; R H Fennell
Journal:  Transplantation       Date:  1976-12       Impact factor: 4.939

8.  Expression of the major histocompatibility complex antigens on different liver cellular components in rat and man.

Authors:  I Lautenschlager; P Häyry
Journal:  Scand J Immunol       Date:  1981-10       Impact factor: 3.487

9.  Recurrence of primary biliary cirrhosis after liver transplantation.

Authors:  J Neuberger; B Portmann; B R Macdougall; R Y Calne; R Williams
Journal:  N Engl J Med       Date:  1982-01-07       Impact factor: 91.245

10.  Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

Authors:  H M Shulman; K M Sullivan; P L Weiden; G B McDonald; G E Striker; G E Sale; R Hackman; M S Tsoi; R Storb; E D Thomas
Journal:  Am J Med       Date:  1980-08       Impact factor: 4.965

View more
  42 in total

Review 1.  Liver transplantation. A primer for practicing gastroenterologists, Part I.

Authors:  V J Dindzans; R R Schade; J S Gavaler; R E Tarter; D H Van Thiel
Journal:  Dig Dis Sci       Date:  1989-01       Impact factor: 3.199

Review 2.  Liver transplantation. A primer for practicing gastroenterologists. Part II.

Authors:  V J Dindzans; R R Schade; J S Gavaler; R E Tarter; D H Van Thiel
Journal:  Dig Dis Sci       Date:  1989-02       Impact factor: 3.199

3.  Chronic liver allograft rejection and obliterative arteriopathy: possible pathogenic mechanisms.

Authors:  S Oguma; T Zerbe; B Banner; S Belle; T E Starzl; A J Demetris
Journal:  Transplant Proc       Date:  1989-02       Impact factor: 1.066

4.  Histologic monitoring of human small bowel allografts with clinical correlation.

Authors:  K Nakamura; S Todo; K Abu-Elmagd; J Reyes; A Tzakis; J J Fung; T E Starzl; A J Demetris
Journal:  Transplant Proc       Date:  1992-06       Impact factor: 1.066

5.  The lymphocytotoxic crossmatch in liver transplantation: a clinicopathologic analysis.

Authors:  K Nakamura; A Yagihashi; Y Iwaki; S Takaya; G G Hartman; N Murase; O Bronsther; R Manez; J J Fung; S Iwatsuki
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

6.  Serum interleukin-6 levels as an indicator of acute rejection after liver transplantation in cynomologous monkeys.

Authors:  H Ohzato; M Monden; K Yoshizaki; M Gotoh; T Kanai; K Umeshita; T Tono; N Nishimoto; T Kishimoto; T Mori
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

7.  Expression of vascular cell adhesion molecule (VCAM-1) in liver and pancreas allograft rejection.

Authors:  C E Bacchi; C L Marsh; J D Perkins; R L Carithers; J P McVicar; K L Hudkins; C D Benjamin; J M Harlan; R Lobb; C E Alpers
Journal:  Am J Pathol       Date:  1993-02       Impact factor: 4.307

8.  Origin of lymph node-derived lymphocytes in human hepatic allografts.

Authors:  John J Fung; Adriane Zeevi; A Jake Demetris; Thomas E Starzl; Bernd Markus; Kangnian Chen; Marilyn Marrarri; Rene J Duquesnoy
Journal:  Clin Transpl       Date:  1989

9.  Recurrent hepatitis B in liver allograft recipients. Differentiation between viral hepatitis B and rejection.

Authors:  A J Demetris; R Jaffe; D G Sheahan; J Burnham; J Spero; S Iwatsuki; D H Van Theil; T E Starzl
Journal:  Am J Pathol       Date:  1986-10       Impact factor: 4.307

10.  Vascular complications after liver transplantation: a 5-year experience.

Authors:  P Wozney; A B Zajko; K M Bron; S Point; T E Starzl
Journal:  AJR Am J Roentgenol       Date:  1986-10       Impact factor: 3.959

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.